12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Financial News  |  Other Financial News

Cytos financial update

Cytos Biotechnology AG (SIX:CYTN), Zurich, Switzerland
Business: Neurology, Inflammation, Cardiovascular
Date announced: 12/12/11
Cytos said bondholders approved a restructuring proposal to prevent Cytos from defaulting on the CHF38.7 million ($41.8...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >